发布求助
文献互助 智能选刊 最新文献

Current Reviews in Clinical and Experimental Pharmacology最新文献

筛选
英文 中文
Meet the Section Editor 见栏目编辑
IF 1.1
Current Reviews in Clinical and Experimental Pharmacology Pub Date : 2021-10-01 DOI: 10.2174/277243281604211015122308
Ya-yun Wang
{"title":"Meet the Section Editor","authors":"Ya-yun Wang","doi":"10.2174/277243281604211015122308","DOIUrl":"https://doi.org/10.2174/277243281604211015122308","url":null,"abstract":"","PeriodicalId":29871,"journal":{"name":"Current Reviews in Clinical and Experimental Pharmacology","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41590937","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Meet the Associate Editorial Board Member 会见副编辑委员会成员
IF 1.1
Current Reviews in Clinical and Experimental Pharmacology Pub Date : 2021-09-22 DOI: 10.2174/277243281603210802093312
M. Spanakis
{"title":"Meet the Associate Editorial Board Member","authors":"M. Spanakis","doi":"10.2174/277243281603210802093312","DOIUrl":"https://doi.org/10.2174/277243281603210802093312","url":null,"abstract":"","PeriodicalId":29871,"journal":{"name":"Current Reviews in Clinical and Experimental Pharmacology","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2021-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43095707","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Notice of Withdrawal 撤回通知
IF 1.1
Current Reviews in Clinical and Experimental Pharmacology Pub Date : 2021-08-31 DOI: 10.2174/2772432816666210901105513
Gaetano Gorgone, Massimiliano Plastino, Antonio Vaccaro, Antonietta Fava, Domenico Bosco
{"title":"Notice of Withdrawal","authors":"Gaetano Gorgone,&nbsp;Massimiliano Plastino,&nbsp;Antonio Vaccaro,&nbsp;Antonietta Fava,&nbsp;Domenico Bosco","doi":"10.2174/2772432816666210901105513","DOIUrl":"https://doi.org/10.2174/2772432816666210901105513","url":null,"abstract":"<p><p>Bentham Science apologizes to the readers of the journal for any inconvenience this may have caused.</p><p><p>The Bentham Editorial Policy on Article Withdrawal can be found at https://benthamscience.com/editorialpolicies-main.php.</p><p><strong>Bentham science disclaimer: </strong>It is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultaneously\u0000submitted or published elsewhere. Furthermore, any data, illustration, structure or table that has been published elsewhere\u0000must be reported, and copyright permission for reproduction must be obtained. Plagiarism is strictly forbidden, and by submitting\u0000the article for publication the authors agree that the publishers have the legal right to take appropriate action against the\u0000authors, if plagiarism or fabricated information is discovered. By submitting a manuscript, the authors agree that the copyright\u0000of their article is transferred to the publishers if and when the article is accepted for publication.</p>","PeriodicalId":29871,"journal":{"name":"Current Reviews in Clinical and Experimental Pharmacology","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2021-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9554757","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Meet The Associate Editorial Board Member 会见副编委
IF 1.1
Current Reviews in Clinical and Experimental Pharmacology Pub Date : 2021-08-03 DOI: 10.2174/277243281602210610114054
Sherif Hassan
{"title":"Meet The Associate Editorial Board Member","authors":"Sherif Hassan","doi":"10.2174/277243281602210610114054","DOIUrl":"https://doi.org/10.2174/277243281602210610114054","url":null,"abstract":"","PeriodicalId":29871,"journal":{"name":"Current Reviews in Clinical and Experimental Pharmacology","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2021-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42281603","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Berberine Nanoencapsulation Attenuates Hallmarks of Scoplomine Induced Alzheimer's-Like Disease in Rats 小檗碱纳米胶囊化可减弱莨菪碱诱导的大鼠阿尔茨海默病的特征
IF 1.1
Current Reviews in Clinical and Experimental Pharmacology Pub Date : 2021-05-01 DOI: 10.2174/2772432mta3rnzqm0
Samar R. Saleh
{"title":"Berberine Nanoencapsulation Attenuates Hallmarks of Scoplomine Induced Alzheimer's-Like Disease in Rats","authors":"Samar R. Saleh","doi":"10.2174/2772432mta3rnzqm0","DOIUrl":"https://doi.org/10.2174/2772432mta3rnzqm0","url":null,"abstract":"","PeriodicalId":29871,"journal":{"name":"Current Reviews in Clinical and Experimental Pharmacology","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2021-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41774592","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Effects of ADJUVANT Ketamine on Induction of Anesthesia for the Cesarean Section ADJUVANT氯胺酮对剖宫产麻醉诱导的影响
IF 1.1
Current Reviews in Clinical and Experimental Pharmacology Pub Date : 2021-05-01 DOI: 10.2174/2772432mta1emtedw
Mahmoudreza Moradkhani
{"title":"Effects of ADJUVANT Ketamine on Induction of Anesthesia for the Cesarean Section","authors":"Mahmoudreza Moradkhani","doi":"10.2174/2772432mta1emtedw","DOIUrl":"https://doi.org/10.2174/2772432mta1emtedw","url":null,"abstract":"","PeriodicalId":29871,"journal":{"name":"Current Reviews in Clinical and Experimental Pharmacology","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2021-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46333599","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of Brain Imaging in Drug Development for Psychiatry. 脑成像在精神病学药物开发中的作用。
IF 1.1
Current Reviews in Clinical and Experimental Pharmacology Pub Date : 2021-03-22 DOI: 10.2174/1574884716666210322143458
J. D. den Boer, E. D. de Vries, R. Borra, A. Waarde, A. Lammertsma, R. Dierckx
{"title":"Role of Brain Imaging in Drug Development for Psychiatry.","authors":"J. D. den Boer, E. D. de Vries, R. Borra, A. Waarde, A. Lammertsma, R. Dierckx","doi":"10.2174/1574884716666210322143458","DOIUrl":"https://doi.org/10.2174/1574884716666210322143458","url":null,"abstract":"BACKGROUND\u0000Over the last decades, many brain imaging studies have contributed to new insights in the pathogenesis of psychiatric disease. However, in spite of these developments, progress in the development of novel therapeutic drugs for prevalent psychiatric health conditions has been limited.\u0000\u0000\u0000OBJECTIVE\u0000In this review, we discuss translational, diagnostic and methodological issues that have hampered drug development in CNS disorders with a particular focus on psychiatry. The role of preclinical models is critically reviewed and opportunities for brain imaging in early stages of drug development using PET and fMRI are discussed. The role of PET and fMRI in drug development is reviewed emphasizing the need to engage in collaborations between industry, academia and phase I units.\u0000\u0000\u0000RESULTS\u0000Brain imaging technology has revolutionized the study of psychiatric illnesses, and during the last decade, neuroimaging has provided valuable insights at different levels of analysis and brain organization, such as effective connectivity (anatomical), functional connectivity patterns and neurochemical information that may support both preclinical and clinical drug development.\u0000\u0000\u0000CONCLUSION\u0000Since there is no unifying pathophysiological theory of individual psychiatric syndromes and since many symptoms cut across diagnostic boundaries, a new theoretical framework has been proposed that may help in defining new targets for treatment and thus enhance drug development in CNS diseases. In addition, it is argued that new proposals for data-mining and mathematical modelling as well as freely available databanks for neural network and neurochemical models of rodents combined with revised psychiatric classification will lead to new validated targets for drug development.","PeriodicalId":29871,"journal":{"name":"Current Reviews in Clinical and Experimental Pharmacology","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2021-03-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43931177","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Angiotensin-Receptor Blockers and the Risk of Alzheimer´s Disease: A Meta-analysis 血管紧张素受体阻滞剂与AlzheimerÂ疾病风险的meta分析
IF 1.1
Current Reviews in Clinical and Experimental Pharmacology Pub Date : 2021-02-01 DOI: 10.2174/2772432mta0imtmcx
T. Oscanoa
{"title":"Angiotensin-Receptor Blockers and the Risk of Alzheimer´s Disease: A Meta-analysis","authors":"T. Oscanoa","doi":"10.2174/2772432mta0imtmcx","DOIUrl":"https://doi.org/10.2174/2772432mta0imtmcx","url":null,"abstract":"","PeriodicalId":29871,"journal":{"name":"Current Reviews in Clinical and Experimental Pharmacology","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2021-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49229151","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
The Interplay of Disease Modifying Anti Rheumatic Drugs and Tuberculin Skin Test. 抗风湿药物与结核菌素皮肤试验的相互作用。
IF 1.1
Current Reviews in Clinical and Experimental Pharmacology Pub Date : 2021-01-01 DOI: 10.2174/1574884715999201231201538
Zia Abdullah, Arvind Kumar, M A Khan, Uma Kumar, Surabhi Vyas, Vishal K Vishwakarma, Piyush Ranjan, Ashutosh Biswas, Naveet Wig
{"title":"The Interplay of Disease Modifying Anti Rheumatic Drugs and Tuberculin Skin Test.","authors":"Zia Abdullah,&nbsp;Arvind Kumar,&nbsp;M A Khan,&nbsp;Uma Kumar,&nbsp;Surabhi Vyas,&nbsp;Vishal K Vishwakarma,&nbsp;Piyush Ranjan,&nbsp;Ashutosh Biswas,&nbsp;Naveet Wig","doi":"10.2174/1574884715999201231201538","DOIUrl":"https://doi.org/10.2174/1574884715999201231201538","url":null,"abstract":"<p><strong>Objective: </strong>The study was conducted to determine whether synthetic Disease-Modifying Anti Rheumatic Drugs (DMARDs) suppress the latency of Tuberculosis (TB) infection in Rheumatoid Arthritis (RA) patients along with other variables.</p><p><strong>Methods: </strong>This was done through Tuberculin Skin Test (TST) using purified protein derivative (PPD) in a cohort of RA patients. The TST was taken positive when induration post-PPD injection was ≥ 5mm and negative or anergic when it was < 5mm. We included 100 patients (N = 100).</p><p><strong>Results: </strong>The prevalence of positive TST was 36%, while 64% presented a negative result. Negative TST was significantly associated with steroid usage (39.4%, 95% CI: 28.4%-51.4%). Anergic (TST negative) and non-anergic (TST positive) patients were separated into groups, and a new analysis was conducted with elaboration on DMARDs used.</p><p><strong>Conclusion: </strong>The use of steroids was associated with TST negativity, The same is not true with use of methotrexate or other DMARDs. Thus TST should be interpreted with caution, especially before starting biologicals.</p>","PeriodicalId":29871,"journal":{"name":"Current Reviews in Clinical and Experimental Pharmacology","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39122088","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Use of Angiotensin Receptor Blockers and Risk of Alzheimer's Disease: A Class Effect? 血管紧张素受体阻滞剂的使用与阿尔茨海默病的风险:一类效应?
IF 1.1
Current Reviews in Clinical and Experimental Pharmacology Pub Date : 2021-01-01 DOI: 10.2174/157488471601210222092911
Arduino A Mangoni, Elzbieta A Jarmuzewska
{"title":"Use of Angiotensin Receptor Blockers and Risk of Alzheimer's Disease: A Class Effect?","authors":"Arduino A Mangoni,&nbsp;Elzbieta A Jarmuzewska","doi":"10.2174/157488471601210222092911","DOIUrl":"https://doi.org/10.2174/157488471601210222092911","url":null,"abstract":"","PeriodicalId":29871,"journal":{"name":"Current Reviews in Clinical and Experimental Pharmacology","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39423736","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信